WO/2004/003138 is referenced by 71 patents.

The present invention provides nucleoside compounds and certain derivatives thereof which are inhibitors of RNA-dependent RNA viral polymerase. These compounds are inhibitors of RNA-dependent RNA viral replication and are useful for the treatment of RNA-dependent RNA viral infection. They are particularly useful as inhibitors of hepatitis C virus (HCV) NS5B polymerase, as inhibitors of HCV replication, and/or for the treatment of hepatitis C infection. The invention also describes pharmaceutical compositions containing such nucleoside compounds alone or in combination with other agents active against RNA-dependent RNA viral infection, in particular HCV infection. Also disclosed are methods of inhibiting RNA-dependent RNA polymerase, inhibiting RNA-dependent RNA viral replication, and/or treating RNA-dependent RNA viral infection with the nucleoside compounds of the present invention.

Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase
Application Number
Publication Number
Application Date
June 23, 2003
Publication Date
January 8, 2004
Eldrup Anne B
Bhat Balkrishen
Maccoss Malcolm
Olsen David B
MERCK 126 East Lincoln Avenue Rahway NJ 07065 0907
Eldrup Anne B
Bhat Balkrishen
Maccoss Malcolm
Olsen David B
Isis Pharmaceuticals
Merck & Co
C07H 19/167
C07H 19/14
A61K 31/70
View Original Source